| Ali Alamar Md A Professional Corp | |
|
2658 Del Mar Heights Rd # 504 Del Mar CA 92014-3100 | |
| (619) 402-4919 | |
| Not Available |
| Full Name | Ali Alamar Md A Professional Corp |
|---|---|
| Speciality | Internal Medicine |
| Location | 2658 Del Mar Heights Rd # 504, Del Mar, California |
| Authorized Official Name and Position | Ali Alamar (PRESIDENT) |
| Authorized Official Contact | 6194024919 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ali Alamar Md A Professional Corp 2658 Del Mar Heights Rd # 504 Del Mar CA 92014-3100 Ph: (619) 402-4919 | Ali Alamar Md A Professional Corp 2658 Del Mar Heights Rd # 504 Del Mar CA 92014-3100 Ph: (619) 402-4919 |
| NPI Number | 1851497465 |
|---|---|
| Provider Enumeration Date | 09/15/2006 |
| Last Update Date | 12/04/2014 |
| Medicare PECOS PAC ID | 5698803971 |
|---|---|
| Medicare Enrollment ID | O20100506000550 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851497465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A69613 (California) | Primary |
| Provider Name | Ali Alamar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972606374 PECOS PAC ID: 6103960604 Enrollment ID: I20100222000763 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Anna C Baston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649588005 PECOS PAC ID: 3577749076 Enrollment ID: I20110518000273 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Linda Yousif Rouel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1326128950 PECOS PAC ID: 1254425168 Enrollment ID: I20150930003467 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Zhike Pruett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295086262 PECOS PAC ID: 6406139229 Enrollment ID: I20170201002015 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Hyacinth Pasco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376065136 PECOS PAC ID: 1658645981 Enrollment ID: I20170925002609 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Eugenie Lei Setiawan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871032870 PECOS PAC ID: 6709144538 Enrollment ID: I20171227000962 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Kirk Anthony Hall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710406848 PECOS PAC ID: 8820334824 Enrollment ID: I20190111002541 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
| Provider Name | Mandeep Kaur |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376213793 PECOS PAC ID: 7113325952 Enrollment ID: I20211008002664 |
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
News Archive
A team of prominent researchers led by Charles Sawyers, M.D. and Moshe Talpaz, M.D., presented compelling clinical findings today showing that a new drug, BMS-354825, can successfully treat patients who have become resistant to Gleevec (the frontline therapy for chronic myelogenous leukemia, CML).
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
College students who viewed alcohol advertisements that included objectified images of women were less likely than others to report intentions to intervene in alcohol-facilitated sexual assault situations in a study published in the Journal of Health Communication.
› Verified 9 days ago
Del Mar Integrative Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1349 Camino Del Mar Ste B, Del Mar, CA 92014 Phone: 858-925-8233 Fax: 858-925-8218 | |
Jennifer Tran Do, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 445 Marine View Ave Ste 300, Del Mar, CA 92014 Phone: 858-740-7087 Fax: 858-997-2591 | |
Michael Markopoulos Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2683 Via De La Valle, Suite G626, Del Mar, CA 92014 Phone: 858-481-0412 | |
Paul J Haydu Md A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1561 San Dieguito Dr, Del Mar, CA 92014 Phone: 858-481-0145 | |
Del Mar Integrative Medicne Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1349 Camino Del Mar, Suite B, Del Mar, CA 92014 Phone: 858-755-0084 Fax: 858-712-4587 | |
Cameron S Francis Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1431 Camino Del Mar, Del Mar, CA 92014 Phone: 858-450-1555 Fax: 858-450-1527 | |
Larson Medical Group, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1442 Camino Del Mar Ste 212, Del Mar, CA 92014 Phone: 760-634-1704 |